Cotikis Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cotikis Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cotikis Phase Today - Breaking & Trending Today

OSE Immunotherapeutics SA: OSE Immunotherapeutics to Continue the Clinical Development in Ulcerative Colitis with Full Rights to Lusvertikimab

Published: May 12, 2023

First-in-class Lusvertikimab (OSE-127) is the most advanced anti-IL-7R mAb. Ongoing clinical Phase 2 trial in Ulcerative Colitis sponsored by OSE Immunotherapeutics after positive futility

Source: finanznachrichten.de

Related Topics:

United StatesFrance GeneralNicolas PoirierThomas GuillotFlorence PortejoieNantes University HospitalBoehringer IngelheimAmerican Society Of HematologyVeloxis Pharmaceuticals IncFirst In Class LusvertikimabUlcerative ColitisAcute Lymphoblastic LeukemiaChief Executive OfficerCotikis PhaseInflammatory Bowel DiseaseAmerican SocietyMultiple RolesHuman StudyHealthy SubjectsStrict AntagonistNon Small Cell Lung CancerVeloxis PharmaceuticalsUniversal Registration DocumentGefallene Big Techs